To further investigate the effect of HIF-1–mediated ITGB3 expression on the migration and invasion of brain-metastatic BC cells, we pharmacologically inhibited HIF-1 or ITGB3 by treating cells with digoxin or cilengitide, respectively. This evidence concerns the gene HIF1A and breast cancer.